ScoreNeurology
Modified Erasmus GBS Outcome Score (mEGOS) on day 7 of admission
Predicts the probability of being unable to walk unaided at 4 weeks, 3 and 6 months in Guillain-Barré syndrome.
Updated 31 October 2026
When to use it
Patients with Guillain-Barré syndrome on day 7 of admission, to estimate motor prognosis, inform families and select patients for trials.
What it needs
- Age at symptom onset
- Diarrhoea in the 4 weeks before weakness
- MRC sum score on day 7 of admission
The points for each answer and the automatic total are in the app.
How to interpret it
The result is read in its clinical context; the app shows it with its units and warnings.
Practical tip
The higher the score, the higher the probability of not walking independently; exact probabilities are read from the curves in the original article.
3 more practical tips in the app.
Reference
- Walgaard C, Lingsma HF, Ruts L, van Doorn PA, Steyerberg EW, Jacobs BC. Early recognition of poor prognosis in Guillain-Barré syndrome. Neurology. 2011;76(11):968-975.
- Doets AY, Lingsma HF, Walgaard C, et al. Predicting outcome in Guillain-Barré syndrome: international validation of the modified Erasmus GBS Outcome Score. Neurology. 2022;98(5):e518-e532.
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
